Inflammatory response time course, HUVEC (Wada et al., 2009)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
HIC2
|
ENSG00000169635.5 | HIC ZBTB transcriptional repressor 2 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
HIC2 | hg19_v2_chr22_+_21771656_21771693 | -0.34 | 9.3e-02 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr1_+_101185290 | 2.11 |
ENST00000370119.4
ENST00000347652.2 ENST00000294728.2 ENST00000370115.1 |
VCAM1
|
vascular cell adhesion molecule 1 |
chr5_-_131826457 | 2.05 |
ENST00000437654.1
ENST00000245414.4 |
IRF1
|
interferon regulatory factor 1 |
chr5_+_131409476 | 1.84 |
ENST00000296871.2
|
CSF2
|
colony stimulating factor 2 (granulocyte-macrophage) |
chr14_+_103592636 | 1.60 |
ENST00000333007.1
|
TNFAIP2
|
tumor necrosis factor, alpha-induced protein 2 |
chr19_+_10381769 | 1.29 |
ENST00000423829.2
ENST00000588645.1 |
ICAM1
|
intercellular adhesion molecule 1 |
chr10_+_6244829 | 1.24 |
ENST00000317350.4
ENST00000379785.1 ENST00000379782.3 ENST00000360521.2 ENST00000379775.4 |
PFKFB3
|
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 |
chr1_+_33231268 | 1.23 |
ENST00000373480.1
|
KIAA1522
|
KIAA1522 |
chr12_-_322504 | 1.22 |
ENST00000424061.2
|
SLC6A12
|
solute carrier family 6 (neurotransmitter transporter), member 12 |
chr19_+_13261216 | 1.22 |
ENST00000587885.1
ENST00000292433.3 |
IER2
|
immediate early response 2 |
chr6_+_14117872 | 1.18 |
ENST00000379153.3
|
CD83
|
CD83 molecule |
chr16_+_57406368 | 1.14 |
ENST00000006053.6
ENST00000563383.1 |
CX3CL1
|
chemokine (C-X3-C motif) ligand 1 |
chr3_-_39195037 | 1.13 |
ENST00000273153.5
|
CSRNP1
|
cysteine-serine-rich nuclear protein 1 |
chr17_-_3595181 | 1.11 |
ENST00000552050.1
|
P2RX5
|
purinergic receptor P2X, ligand-gated ion channel, 5 |
chr19_-_46288917 | 1.11 |
ENST00000537879.1
ENST00000596586.1 ENST00000595946.1 |
DMWD
AC011530.4
|
dystrophia myotonica, WD repeat containing Uncharacterized protein |
chr4_-_7436671 | 1.10 |
ENST00000319098.4
|
PSAPL1
|
prosaposin-like 1 (gene/pseudogene) |
chr6_+_138188551 | 1.04 |
ENST00000237289.4
ENST00000433680.1 |
TNFAIP3
|
tumor necrosis factor, alpha-induced protein 3 |
chr6_-_39282329 | 1.03 |
ENST00000373231.4
|
KCNK17
|
potassium channel, subfamily K, member 17 |
chr6_-_39282221 | 1.00 |
ENST00000453413.2
|
KCNK17
|
potassium channel, subfamily K, member 17 |
chr2_-_235405168 | 0.98 |
ENST00000339728.3
|
ARL4C
|
ADP-ribosylation factor-like 4C |
chr6_-_37225391 | 0.97 |
ENST00000356757.2
|
TMEM217
|
transmembrane protein 217 |
chr6_-_37225367 | 0.95 |
ENST00000336655.2
|
TMEM217
|
transmembrane protein 217 |
chr3_+_32147997 | 0.94 |
ENST00000282541.5
|
GPD1L
|
glycerol-3-phosphate dehydrogenase 1-like |
chrX_-_131623874 | 0.93 |
ENST00000436215.1
|
MBNL3
|
muscleblind-like splicing regulator 3 |
chr1_-_165324983 | 0.88 |
ENST00000367893.4
|
LMX1A
|
LIM homeobox transcription factor 1, alpha |
chr16_-_75300679 | 0.85 |
ENST00000420641.3
|
BCAR1
|
breast cancer anti-estrogen resistance 1 |
chr8_+_67344710 | 0.84 |
ENST00000379385.4
ENST00000396623.3 ENST00000415254.1 |
ADHFE1
|
alcohol dehydrogenase, iron containing, 1 |
chr5_-_139726181 | 0.79 |
ENST00000507104.1
ENST00000230990.6 |
HBEGF
|
heparin-binding EGF-like growth factor |
chr18_+_77155856 | 0.78 |
ENST00000253506.5
ENST00000591814.1 |
NFATC1
|
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1 |
chr8_+_90770008 | 0.77 |
ENST00000540020.1
|
RIPK2
|
receptor-interacting serine-threonine kinase 2 |
chr11_-_44972418 | 0.76 |
ENST00000525680.1
ENST00000528290.1 ENST00000530035.1 |
TP53I11
|
tumor protein p53 inducible protein 11 |
chr12_-_322821 | 0.76 |
ENST00000359674.4
|
SLC6A12
|
solute carrier family 6 (neurotransmitter transporter), member 12 |
chr4_+_156588806 | 0.76 |
ENST00000513574.1
|
GUCY1A3
|
guanylate cyclase 1, soluble, alpha 3 |
chr11_-_44972390 | 0.74 |
ENST00000395648.3
ENST00000531928.2 |
TP53I11
|
tumor protein p53 inducible protein 11 |
chr22_+_33197683 | 0.74 |
ENST00000266085.6
|
TIMP3
|
TIMP metallopeptidase inhibitor 3 |
chr16_+_56642489 | 0.73 |
ENST00000561491.1
|
MT2A
|
metallothionein 2A |
chr4_+_156588350 | 0.72 |
ENST00000296518.7
|
GUCY1A3
|
guanylate cyclase 1, soluble, alpha 3 |
chr19_+_44116236 | 0.72 |
ENST00000417606.1
|
SRRM5
|
serine/arginine repetitive matrix 5 |
chr16_-_66952779 | 0.72 |
ENST00000570262.1
ENST00000394055.3 ENST00000299752.4 |
CDH16
|
cadherin 16, KSP-cadherin |
chr16_-_66952742 | 0.72 |
ENST00000565235.2
ENST00000568632.1 ENST00000565796.1 |
CDH16
|
cadherin 16, KSP-cadherin |
chr5_-_141704566 | 0.72 |
ENST00000344120.4
ENST00000434127.2 |
SPRY4
|
sprouty homolog 4 (Drosophila) |
chr16_-_11485922 | 0.71 |
ENST00000599216.1
|
CTD-3088G3.8
|
Protein LOC388210 |
chr19_-_13261090 | 0.71 |
ENST00000588848.1
|
STX10
|
syntaxin 10 |
chr11_-_118023490 | 0.71 |
ENST00000324727.4
|
SCN4B
|
sodium channel, voltage-gated, type IV, beta subunit |
chr19_-_13260992 | 0.70 |
ENST00000242770.5
ENST00000589083.1 ENST00000587230.1 |
STX10
|
syntaxin 10 |
chrX_-_131623982 | 0.67 |
ENST00000370844.1
|
MBNL3
|
muscleblind-like splicing regulator 3 |
chr17_-_73874654 | 0.67 |
ENST00000254816.2
|
TRIM47
|
tripartite motif containing 47 |
chr2_-_24583314 | 0.67 |
ENST00000443927.1
ENST00000406921.3 ENST00000412011.1 |
ITSN2
|
intersectin 2 |
chrX_-_153279697 | 0.67 |
ENST00000444254.1
|
IRAK1
|
interleukin-1 receptor-associated kinase 1 |
chr14_+_93897272 | 0.67 |
ENST00000393151.2
|
UNC79
|
unc-79 homolog (C. elegans) |
chrX_+_68048803 | 0.66 |
ENST00000204961.4
|
EFNB1
|
ephrin-B1 |
chr6_-_143266297 | 0.66 |
ENST00000367603.2
|
HIVEP2
|
human immunodeficiency virus type I enhancer binding protein 2 |
chr3_+_111393659 | 0.65 |
ENST00000477665.1
|
PLCXD2
|
phosphatidylinositol-specific phospholipase C, X domain containing 2 |
chr6_+_31865552 | 0.63 |
ENST00000469372.1
ENST00000497706.1 |
C2
|
complement component 2 |
chr19_-_13261160 | 0.63 |
ENST00000343587.5
ENST00000591197.1 |
STX10
|
syntaxin 10 |
chr17_+_73997796 | 0.63 |
ENST00000586261.1
|
CDK3
|
cyclin-dependent kinase 3 |
chr3_+_46449049 | 0.62 |
ENST00000357392.4
ENST00000400880.3 ENST00000433848.1 |
CCRL2
|
chemokine (C-C motif) receptor-like 2 |
chr5_-_41261540 | 0.62 |
ENST00000263413.3
|
C6
|
complement component 6 |
chr9_+_124088860 | 0.61 |
ENST00000373806.1
|
GSN
|
gelsolin |
chr19_+_15160130 | 0.60 |
ENST00000427043.3
|
CASP14
|
caspase 14, apoptosis-related cysteine peptidase |
chr16_+_2097403 | 0.59 |
ENST00000219476.3
|
TSC2
|
tuberous sclerosis 2 |
chr4_+_8201091 | 0.59 |
ENST00000382521.3
ENST00000245105.3 ENST00000457650.2 ENST00000539824.1 |
SH3TC1
|
SH3 domain and tetratricopeptide repeats 1 |
chr8_+_90769967 | 0.59 |
ENST00000220751.4
|
RIPK2
|
receptor-interacting serine-threonine kinase 2 |
chr9_-_95896550 | 0.59 |
ENST00000375446.4
|
NINJ1
|
ninjurin 1 |
chr5_+_179247759 | 0.58 |
ENST00000389805.4
ENST00000504627.1 ENST00000402874.3 ENST00000510187.1 |
SQSTM1
|
sequestosome 1 |
chr14_+_105939276 | 0.57 |
ENST00000483017.3
|
CRIP2
|
cysteine-rich protein 2 |
chr19_+_56717283 | 0.57 |
ENST00000376267.1
|
ZSCAN5C
|
zinc finger and SCAN domain containing 5C |
chr17_+_21191341 | 0.56 |
ENST00000526076.2
ENST00000361818.5 ENST00000316920.6 |
MAP2K3
|
mitogen-activated protein kinase kinase 3 |
chr3_+_10206545 | 0.56 |
ENST00000256458.4
|
IRAK2
|
interleukin-1 receptor-associated kinase 2 |
chr6_-_55443958 | 0.56 |
ENST00000370850.2
|
HMGCLL1
|
3-hydroxymethyl-3-methylglutaryl-CoA lyase-like 1 |
chr17_+_43238438 | 0.56 |
ENST00000593138.1
ENST00000586681.1 |
HEXIM2
|
hexamethylene bis-acetamide inducible 2 |
chr9_-_131486367 | 0.56 |
ENST00000372663.4
ENST00000406904.2 ENST00000452105.1 ENST00000372672.2 ENST00000372667.5 |
ZDHHC12
|
zinc finger, DHHC-type containing 12 |
chr11_+_124609742 | 0.56 |
ENST00000284292.6
|
NRGN
|
neurogranin (protein kinase C substrate, RC3) |
chr7_+_155090271 | 0.56 |
ENST00000476756.1
|
INSIG1
|
insulin induced gene 1 |
chr10_+_82297658 | 0.55 |
ENST00000339284.2
|
SH2D4B
|
SH2 domain containing 4B |
chr11_+_65408273 | 0.55 |
ENST00000394227.3
|
SIPA1
|
signal-induced proliferation-associated 1 |
chr11_+_61717842 | 0.55 |
ENST00000449131.2
|
BEST1
|
bestrophin 1 |
chr11_+_61717279 | 0.55 |
ENST00000378043.4
|
BEST1
|
bestrophin 1 |
chr12_-_50290839 | 0.54 |
ENST00000552863.1
|
FAIM2
|
Fas apoptotic inhibitory molecule 2 |
chr17_+_32612687 | 0.54 |
ENST00000305869.3
|
CCL11
|
chemokine (C-C motif) ligand 11 |
chr17_+_4736627 | 0.53 |
ENST00000355280.6
ENST00000347992.7 |
MINK1
|
misshapen-like kinase 1 |
chr5_-_141249154 | 0.53 |
ENST00000357517.5
ENST00000536585.1 |
PCDH1
|
protocadherin 1 |
chr9_+_87285257 | 0.53 |
ENST00000323115.4
|
NTRK2
|
neurotrophic tyrosine kinase, receptor, type 2 |
chr19_-_3025614 | 0.53 |
ENST00000447365.2
|
TLE2
|
transducin-like enhancer of split 2 (E(sp1) homolog, Drosophila) |
chr16_-_11681316 | 0.53 |
ENST00000571688.1
|
LITAF
|
lipopolysaccharide-induced TNF factor |
chr14_+_23012122 | 0.52 |
ENST00000390534.1
|
TRAJ3
|
T cell receptor alpha joining 3 |
chr12_-_52911718 | 0.52 |
ENST00000548409.1
|
KRT5
|
keratin 5 |
chr3_-_129035120 | 0.51 |
ENST00000333762.4
|
H1FX
|
H1 histone family, member X |
chr20_-_50159198 | 0.51 |
ENST00000371564.3
ENST00000396009.3 ENST00000610033.1 |
NFATC2
|
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2 |
chr11_+_61717336 | 0.51 |
ENST00000378042.3
|
BEST1
|
bestrophin 1 |
chr17_+_7461613 | 0.50 |
ENST00000438470.1
ENST00000436057.1 |
TNFSF13
|
tumor necrosis factor (ligand) superfamily, member 13 |
chr1_+_203097407 | 0.50 |
ENST00000367235.1
|
ADORA1
|
adenosine A1 receptor |
chr1_+_205473720 | 0.50 |
ENST00000429964.2
ENST00000506784.1 ENST00000360066.2 |
CDK18
|
cyclin-dependent kinase 18 |
chr6_+_43739697 | 0.50 |
ENST00000230480.6
|
VEGFA
|
vascular endothelial growth factor A |
chr12_-_323689 | 0.49 |
ENST00000428720.1
|
SLC6A12
|
solute carrier family 6 (neurotransmitter transporter), member 12 |
chr15_+_90728145 | 0.49 |
ENST00000561085.1
ENST00000379122.3 ENST00000332496.6 |
SEMA4B
|
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4B |
chr15_+_67418047 | 0.49 |
ENST00000540846.2
|
SMAD3
|
SMAD family member 3 |
chr16_+_31119615 | 0.49 |
ENST00000394950.3
ENST00000287507.3 ENST00000219794.6 ENST00000561755.1 |
BCKDK
|
branched chain ketoacid dehydrogenase kinase |
chr1_-_45956800 | 0.49 |
ENST00000538496.1
|
TESK2
|
testis-specific kinase 2 |
chrX_+_153665248 | 0.49 |
ENST00000447750.2
|
GDI1
|
GDP dissociation inhibitor 1 |
chr18_-_45935663 | 0.49 |
ENST00000589194.1
ENST00000591279.1 ENST00000590855.1 ENST00000587107.1 ENST00000588970.1 ENST00000586525.1 ENST00000592387.1 ENST00000590800.1 |
ZBTB7C
|
zinc finger and BTB domain containing 7C |
chr9_-_136006496 | 0.48 |
ENST00000372062.3
|
RALGDS
|
ral guanine nucleotide dissociation stimulator |
chr11_+_5423827 | 0.48 |
ENST00000332043.1
|
OR51J1
|
olfactory receptor, family 51, subfamily J, member 1 (gene/pseudogene) |
chr19_-_12997995 | 0.47 |
ENST00000264834.4
|
KLF1
|
Kruppel-like factor 1 (erythroid) |
chr12_+_57482665 | 0.47 |
ENST00000300131.3
|
NAB2
|
NGFI-A binding protein 2 (EGR1 binding protein 2) |
chr11_+_64002292 | 0.47 |
ENST00000426086.2
|
VEGFB
|
vascular endothelial growth factor B |
chr10_+_82298088 | 0.46 |
ENST00000470604.2
|
SH2D4B
|
SH2 domain containing 4B |
chr22_+_35796056 | 0.46 |
ENST00000216122.4
|
MCM5
|
minichromosome maintenance complex component 5 |
chr1_+_61547894 | 0.46 |
ENST00000403491.3
|
NFIA
|
nuclear factor I/A |
chr22_+_37956453 | 0.46 |
ENST00000249014.4
|
CDC42EP1
|
CDC42 effector protein (Rho GTPase binding) 1 |
chr19_-_45579762 | 0.45 |
ENST00000303809.2
|
ZNF296
|
zinc finger protein 296 |
chr13_+_96204961 | 0.45 |
ENST00000299339.2
|
CLDN10
|
claudin 10 |
chr19_-_15442701 | 0.45 |
ENST00000594841.1
ENST00000601941.1 |
BRD4
|
bromodomain containing 4 |
chr9_+_130853715 | 0.45 |
ENST00000373066.5
ENST00000432073.2 |
SLC25A25
|
solute carrier family 25 (mitochondrial carrier; phosphate carrier), member 25 |
chr1_-_98510843 | 0.44 |
ENST00000413670.2
ENST00000538428.1 |
MIR137HG
|
MIR137 host gene (non-protein coding) |
chr16_+_2098003 | 0.44 |
ENST00000439673.2
ENST00000350773.4 |
TSC2
|
tuberous sclerosis 2 |
chr2_-_89385283 | 0.44 |
ENST00000390252.2
|
IGKV3-15
|
immunoglobulin kappa variable 3-15 |
chr17_+_61562178 | 0.44 |
ENST00000490216.2
|
ACE
|
angiotensin I converting enzyme |
chr16_-_18441131 | 0.44 |
ENST00000339303.5
|
NPIPA8
|
nuclear pore complex interacting protein family, member A8 |
chr19_+_7599597 | 0.44 |
ENST00000414982.3
ENST00000450331.3 |
PNPLA6
|
patatin-like phospholipase domain containing 6 |
chr17_-_34502410 | 0.44 |
ENST00000398801.3
|
TBC1D3B
|
TBC1 domain family, member 3B |
chr11_-_111783595 | 0.43 |
ENST00000528628.1
|
CRYAB
|
crystallin, alpha B |
chr19_+_18530146 | 0.43 |
ENST00000348495.6
ENST00000270061.7 |
SSBP4
|
single stranded DNA binding protein 4 |
chr15_+_84908573 | 0.43 |
ENST00000424966.1
ENST00000422563.2 |
GOLGA6L4
|
golgin A6 family-like 4 |
chr1_+_153746683 | 0.43 |
ENST00000271857.2
|
SLC27A3
|
solute carrier family 27 (fatty acid transporter), member 3 |
chr16_+_30662184 | 0.43 |
ENST00000300835.4
|
PRR14
|
proline rich 14 |
chr2_+_85360499 | 0.43 |
ENST00000282111.3
|
TCF7L1
|
transcription factor 7-like 1 (T-cell specific, HMG-box) |
chr17_+_1674982 | 0.43 |
ENST00000572048.1
ENST00000573763.1 |
SERPINF1
|
serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1 |
chr19_+_17516531 | 0.43 |
ENST00000528911.1
ENST00000528604.1 ENST00000595892.1 ENST00000500836.2 ENST00000598546.1 ENST00000600369.1 ENST00000598356.1 ENST00000594426.1 |
MVB12A
CTD-2521M24.9
|
multivesicular body subunit 12A CTD-2521M24.9 |
chr7_-_37488834 | 0.42 |
ENST00000310758.4
|
ELMO1
|
engulfment and cell motility 1 |
chr3_+_52529346 | 0.42 |
ENST00000321725.6
|
STAB1
|
stabilin 1 |
chr11_-_35440579 | 0.42 |
ENST00000606205.1
|
SLC1A2
|
solute carrier family 1 (glial high affinity glutamate transporter), member 2 |
chr19_-_51017881 | 0.42 |
ENST00000601207.1
ENST00000598657.1 ENST00000376916.3 |
ASPDH
|
aspartate dehydrogenase domain containing |
chr12_-_55042140 | 0.42 |
ENST00000293371.6
ENST00000456047.2 |
DCD
|
dermcidin |
chr16_-_11492366 | 0.41 |
ENST00000595360.1
|
CTD-3088G3.8
|
Protein LOC388210 |
chr22_+_35796108 | 0.41 |
ENST00000382011.5
ENST00000416905.1 |
MCM5
|
minichromosome maintenance complex component 5 |
chr19_+_7600584 | 0.41 |
ENST00000600737.1
|
PNPLA6
|
patatin-like phospholipase domain containing 6 |
chr16_+_2097970 | 0.41 |
ENST00000382538.6
ENST00000401874.2 ENST00000353929.4 |
TSC2
|
tuberous sclerosis 2 |
chr17_+_42427826 | 0.41 |
ENST00000586443.1
|
GRN
|
granulin |
chr4_+_156588115 | 0.41 |
ENST00000455639.2
|
GUCY1A3
|
guanylate cyclase 1, soluble, alpha 3 |
chr17_+_7792101 | 0.41 |
ENST00000358181.4
ENST00000330494.7 |
CHD3
|
chromodomain helicase DNA binding protein 3 |
chr8_+_22424551 | 0.40 |
ENST00000523348.1
|
SORBS3
|
sorbin and SH3 domain containing 3 |
chr1_-_1149506 | 0.40 |
ENST00000379236.3
|
TNFRSF4
|
tumor necrosis factor receptor superfamily, member 4 |
chr17_+_61562201 | 0.40 |
ENST00000290863.6
ENST00000413513.3 ENST00000421982.2 |
ACE
|
angiotensin I converting enzyme |
chr17_+_40440481 | 0.40 |
ENST00000590726.2
ENST00000452307.2 ENST00000444283.1 ENST00000588868.1 |
STAT5A
|
signal transducer and activator of transcription 5A |
chr2_+_201994042 | 0.40 |
ENST00000417748.1
|
CFLAR
|
CASP8 and FADD-like apoptosis regulator |
chr5_-_131347501 | 0.40 |
ENST00000543479.1
|
ACSL6
|
acyl-CoA synthetase long-chain family member 6 |
chr19_-_11347173 | 0.40 |
ENST00000587656.1
|
DOCK6
|
dedicator of cytokinesis 6 |
chr3_+_100354442 | 0.40 |
ENST00000475887.1
|
GPR128
|
G protein-coupled receptor 128 |
chr19_-_11545920 | 0.40 |
ENST00000356392.4
ENST00000591179.1 |
CCDC151
|
coiled-coil domain containing 151 |
chr17_+_21187976 | 0.39 |
ENST00000342679.4
|
MAP2K3
|
mitogen-activated protein kinase kinase 3 |
chr11_-_1593150 | 0.39 |
ENST00000397374.3
|
DUSP8
|
dual specificity phosphatase 8 |
chr22_-_44287875 | 0.39 |
ENST00000438734.1
ENST00000597664.1 ENST00000216177.4 ENST00000593866.1 ENST00000381198.2 |
PNPLA5
|
patatin-like phospholipase domain containing 5 |
chr11_-_63993601 | 0.39 |
ENST00000545812.1
ENST00000394547.3 ENST00000317459.6 |
TRPT1
|
tRNA phosphotransferase 1 |
chr14_+_105046021 | 0.39 |
ENST00000557649.1
|
C14orf180
|
chromosome 14 open reading frame 180 |
chr1_-_156722015 | 0.39 |
ENST00000368209.5
|
HDGF
|
hepatoma-derived growth factor |
chr19_-_50169064 | 0.39 |
ENST00000593337.1
ENST00000598808.1 ENST00000600453.1 ENST00000593818.1 ENST00000597198.1 ENST00000601809.1 ENST00000377139.3 |
IRF3
|
interferon regulatory factor 3 |
chr9_-_130477912 | 0.39 |
ENST00000543175.1
|
PTRH1
|
peptidyl-tRNA hydrolase 1 homolog (S. cerevisiae) |
chr1_-_2461684 | 0.39 |
ENST00000378453.3
|
HES5
|
hes family bHLH transcription factor 5 |
chr6_-_39902160 | 0.39 |
ENST00000340692.5
|
MOCS1
|
molybdenum cofactor synthesis 1 |
chrX_+_152338301 | 0.38 |
ENST00000453825.2
|
PNMA6A
|
paraneoplastic Ma antigen family member 6A |
chr16_+_29817399 | 0.38 |
ENST00000545521.1
|
MAZ
|
MYC-associated zinc finger protein (purine-binding transcription factor) |
chr21_+_33784957 | 0.38 |
ENST00000401402.3
ENST00000382699.3 |
EVA1C
|
eva-1 homolog C (C. elegans) |
chr19_-_50168962 | 0.38 |
ENST00000599223.1
ENST00000593922.1 ENST00000600022.1 ENST00000596765.1 ENST00000599144.1 ENST00000596822.1 ENST00000598108.1 ENST00000601373.1 ENST00000595034.1 ENST00000601291.1 |
IRF3
|
interferon regulatory factor 3 |
chr22_+_39353527 | 0.38 |
ENST00000249116.2
|
APOBEC3A
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3A |
chr15_-_64338521 | 0.38 |
ENST00000457488.1
ENST00000558069.1 |
DAPK2
|
death-associated protein kinase 2 |
chr4_+_156588249 | 0.38 |
ENST00000393832.3
|
GUCY1A3
|
guanylate cyclase 1, soluble, alpha 3 |
chr17_+_36584662 | 0.38 |
ENST00000431231.2
ENST00000437668.3 |
ARHGAP23
|
Rho GTPase activating protein 23 |
chr1_+_110453608 | 0.38 |
ENST00000369801.1
|
CSF1
|
colony stimulating factor 1 (macrophage) |
chr6_-_30712313 | 0.38 |
ENST00000376377.2
ENST00000259874.5 |
IER3
|
immediate early response 3 |
chr19_+_797392 | 0.37 |
ENST00000350092.4
ENST00000349038.4 ENST00000586481.1 ENST00000585535.1 |
PTBP1
|
polypyrimidine tract binding protein 1 |
chr16_-_30122717 | 0.37 |
ENST00000566613.1
|
GDPD3
|
glycerophosphodiester phosphodiesterase domain containing 3 |
chrX_+_149531524 | 0.37 |
ENST00000370401.2
|
MAMLD1
|
mastermind-like domain containing 1 |
chr5_+_80256453 | 0.37 |
ENST00000265080.4
|
RASGRF2
|
Ras protein-specific guanine nucleotide-releasing factor 2 |
chr1_+_33207381 | 0.37 |
ENST00000401073.2
|
KIAA1522
|
KIAA1522 |
chr1_-_155177677 | 0.36 |
ENST00000368378.3
ENST00000541990.1 ENST00000457183.2 |
THBS3
|
thrombospondin 3 |
chr17_+_18218587 | 0.36 |
ENST00000406438.3
|
SMCR8
|
Smith-Magenis syndrome chromosome region, candidate 8 |
chr2_-_235405679 | 0.36 |
ENST00000390645.2
|
ARL4C
|
ADP-ribosylation factor-like 4C |
chr17_-_39661849 | 0.36 |
ENST00000246635.3
ENST00000336861.3 ENST00000587544.1 ENST00000587435.1 |
KRT13
|
keratin 13 |
chr11_+_64126614 | 0.36 |
ENST00000528057.1
ENST00000334205.4 ENST00000294261.4 |
RPS6KA4
|
ribosomal protein S6 kinase, 90kDa, polypeptide 4 |
chr16_+_56642041 | 0.36 |
ENST00000245185.5
|
MT2A
|
metallothionein 2A |
chr18_-_45663666 | 0.35 |
ENST00000535628.2
|
ZBTB7C
|
zinc finger and BTB domain containing 7C |
chr16_+_88704978 | 0.35 |
ENST00000244241.4
|
IL17C
|
interleukin 17C |
chr11_-_63933504 | 0.35 |
ENST00000255681.6
|
MACROD1
|
MACRO domain containing 1 |
chr6_-_62996066 | 0.35 |
ENST00000281156.4
|
KHDRBS2
|
KH domain containing, RNA binding, signal transduction associated 2 |
chr9_+_139247484 | 0.35 |
ENST00000429455.1
|
GPSM1
|
G-protein signaling modulator 1 |
chr10_-_71169031 | 0.35 |
ENST00000373307.1
|
TACR2
|
tachykinin receptor 2 |
chr22_-_30867973 | 0.35 |
ENST00000402286.1
ENST00000401751.1 ENST00000539629.1 ENST00000403066.1 ENST00000215812.4 |
SEC14L3
|
SEC14-like 3 (S. cerevisiae) |
chr11_+_117063295 | 0.35 |
ENST00000525478.1
ENST00000532062.1 |
SIDT2
|
SID1 transmembrane family, member 2 |
chr15_+_89181974 | 0.35 |
ENST00000306072.5
|
ISG20
|
interferon stimulated exonuclease gene 20kDa |
chr4_+_619347 | 0.35 |
ENST00000255622.6
|
PDE6B
|
phosphodiesterase 6B, cGMP-specific, rod, beta |
chr19_-_55628700 | 0.35 |
ENST00000592993.1
|
PPP1R12C
|
protein phosphatase 1, regulatory subunit 12C |
chr16_+_2205755 | 0.35 |
ENST00000326181.6
|
TRAF7
|
TNF receptor-associated factor 7, E3 ubiquitin protein ligase |
chr22_+_37447771 | 0.35 |
ENST00000402077.3
ENST00000403888.3 ENST00000456470.1 |
KCTD17
|
potassium channel tetramerization domain containing 17 |
chr11_+_64001962 | 0.35 |
ENST00000309422.2
|
VEGFB
|
vascular endothelial growth factor B |
chr2_-_96781984 | 0.35 |
ENST00000409345.3
|
ADRA2B
|
adrenoceptor alpha 2B |
chr13_+_112721913 | 0.35 |
ENST00000330949.1
|
SOX1
|
SRY (sex determining region Y)-box 1 |
chr19_-_17488143 | 0.35 |
ENST00000599426.1
ENST00000252590.4 |
PLVAP
|
plasmalemma vesicle associated protein |
chr2_+_90153696 | 0.35 |
ENST00000417279.2
|
IGKV3D-15
|
immunoglobulin kappa variable 3D-15 (gene/pseudogene) |
chr1_-_237167718 | 0.34 |
ENST00000464121.2
|
MT1HL1
|
metallothionein 1H-like 1 |
chrX_+_48681768 | 0.34 |
ENST00000430858.1
|
HDAC6
|
histone deacetylase 6 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 2.3 | GO:2000564 | CD8-positive, alpha-beta T cell proliferation(GO:0035740) regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000564) |
0.5 | 3.4 | GO:0022614 | membrane to membrane docking(GO:0022614) |
0.4 | 1.1 | GO:0050902 | leukocyte adhesive activation(GO:0050902) |
0.4 | 2.3 | GO:0052551 | response to defense-related nitric oxide production by other organism involved in symbiotic interaction(GO:0052551) response to defense-related host nitric oxide production(GO:0052565) |
0.4 | 1.8 | GO:0045918 | negative regulation of cytolysis(GO:0045918) |
0.3 | 1.0 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
0.3 | 1.2 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.3 | 0.8 | GO:0015993 | molecular hydrogen transport(GO:0015993) |
0.3 | 1.4 | GO:0033091 | positive regulation of immature T cell proliferation(GO:0033091) |
0.2 | 1.1 | GO:0044855 | plasma membrane raft distribution(GO:0044855) plasma membrane raft localization(GO:0044856) plasma membrane raft polarization(GO:0044858) regulation of plasma membrane raft polarization(GO:1903906) |
0.2 | 0.8 | GO:1903597 | negative regulation of gap junction assembly(GO:1903597) |
0.2 | 1.0 | GO:1990169 | detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
0.2 | 0.6 | GO:0038098 | sequestering of BMP from receptor via BMP binding(GO:0038098) |
0.2 | 0.8 | GO:0090301 | regulation of neural crest formation(GO:0090299) negative regulation of neural crest formation(GO:0090301) negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000314) |
0.2 | 0.6 | GO:0034970 | histone H3-R2 methylation(GO:0034970) |
0.2 | 1.0 | GO:0099540 | synaptic signaling via neuropeptide(GO:0099538) trans-synaptic signaling by neuropeptide(GO:0099540) trans-synaptic signaling by neuropeptide, modulating synaptic transmission(GO:0099551) |
0.2 | 0.8 | GO:0051541 | elastin metabolic process(GO:0051541) |
0.2 | 0.9 | GO:0019075 | virus maturation(GO:0019075) |
0.2 | 0.6 | GO:1901301 | regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
0.2 | 0.7 | GO:1903121 | regulation of TRAIL-activated apoptotic signaling pathway(GO:1903121) positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
0.2 | 0.5 | GO:0032900 | regulation of nucleoside transport(GO:0032242) negative regulation of neurotrophin production(GO:0032900) |
0.2 | 0.5 | GO:1903572 | regulation of protein kinase D signaling(GO:1903570) positive regulation of protein kinase D signaling(GO:1903572) |
0.2 | 0.8 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
0.2 | 0.6 | GO:0001970 | positive regulation of activation of membrane attack complex(GO:0001970) |
0.2 | 1.4 | GO:1901525 | negative regulation of macromitophagy(GO:1901525) |
0.2 | 0.9 | GO:0060754 | positive regulation of mast cell chemotaxis(GO:0060754) |
0.1 | 0.9 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.1 | 0.4 | GO:0006427 | histidyl-tRNA aminoacylation(GO:0006427) |
0.1 | 0.4 | GO:0071279 | cellular response to cobalt ion(GO:0071279) |
0.1 | 0.4 | GO:0019364 | NADP catabolic process(GO:0006742) pyridine nucleotide catabolic process(GO:0019364) |
0.1 | 1.8 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.1 | 0.4 | GO:0072185 | metanephric cap development(GO:0072185) metanephric cap morphogenesis(GO:0072186) metanephric cap mesenchymal cell proliferation involved in metanephros development(GO:0090094) |
0.1 | 0.4 | GO:0097187 | dentinogenesis(GO:0097187) |
0.1 | 0.5 | GO:1904647 | response to rotenone(GO:1904647) |
0.1 | 0.5 | GO:0086097 | phospholipase C-activating angiotensin-activated signaling pathway(GO:0086097) |
0.1 | 0.9 | GO:0060763 | mammary duct terminal end bud growth(GO:0060763) |
0.1 | 0.8 | GO:0070560 | protein secretion by platelet(GO:0070560) |
0.1 | 1.0 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
0.1 | 0.5 | GO:0072047 | proximal/distal pattern formation involved in nephron development(GO:0072047) specification of nephron tubule identity(GO:0072081) specification of loop of Henle identity(GO:0072086) |
0.1 | 0.1 | GO:0032899 | regulation of neurotrophin production(GO:0032899) |
0.1 | 2.5 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
0.1 | 0.6 | GO:0035105 | sterol regulatory element binding protein import into nucleus(GO:0035105) |
0.1 | 1.0 | GO:0035897 | proteolysis in other organism(GO:0035897) |
0.1 | 0.4 | GO:0014057 | positive regulation of acetylcholine secretion, neurotransmission(GO:0014057) |
0.1 | 0.3 | GO:0019242 | methylglyoxal biosynthetic process(GO:0019242) |
0.1 | 0.1 | GO:0060584 | regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
0.1 | 0.6 | GO:0042631 | cellular response to water deprivation(GO:0042631) |
0.1 | 0.3 | GO:0036512 | trimming of terminal mannose on B branch(GO:0036509) trimming of first mannose on A branch(GO:0036511) trimming of second mannose on A branch(GO:0036512) |
0.1 | 1.9 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.1 | 0.3 | GO:1904899 | regulation of hepatic stellate cell proliferation(GO:1904897) positive regulation of hepatic stellate cell proliferation(GO:1904899) hepatic stellate cell proliferation(GO:1990922) |
0.1 | 0.7 | GO:0006549 | isoleucine metabolic process(GO:0006549) |
0.1 | 0.3 | GO:0001300 | chronological cell aging(GO:0001300) |
0.1 | 1.3 | GO:0048298 | positive regulation of isotype switching to IgA isotypes(GO:0048298) |
0.1 | 0.4 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
0.1 | 0.3 | GO:0048200 | COPI-coated vesicle budding(GO:0035964) Golgi transport vesicle coating(GO:0048200) COPI coating of Golgi vesicle(GO:0048205) |
0.1 | 0.5 | GO:0061767 | negative regulation of lung blood pressure(GO:0061767) |
0.1 | 0.3 | GO:0001812 | positive regulation of type I hypersensitivity(GO:0001812) |
0.1 | 0.2 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
0.1 | 0.6 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
0.1 | 0.4 | GO:0038195 | urokinase plasminogen activator signaling pathway(GO:0038195) |
0.1 | 1.9 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.1 | 0.3 | GO:1903527 | positive regulation of membrane tubulation(GO:1903527) |
0.1 | 0.4 | GO:1902460 | regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
0.1 | 0.5 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.1 | 0.4 | GO:0098886 | modification of dendritic spine(GO:0098886) |
0.1 | 1.6 | GO:0051601 | exocyst localization(GO:0051601) |
0.1 | 0.2 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
0.1 | 1.2 | GO:0044351 | macropinocytosis(GO:0044351) |
0.1 | 0.3 | GO:0031635 | adenylate cyclase-inhibiting opioid receptor signaling pathway(GO:0031635) negative regulation of Wnt protein secretion(GO:0061358) |
0.1 | 0.3 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
0.1 | 0.3 | GO:0090035 | regulation of chaperone-mediated protein complex assembly(GO:0090034) positive regulation of chaperone-mediated protein complex assembly(GO:0090035) |
0.1 | 0.4 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.1 | 0.3 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
0.1 | 0.2 | GO:0002585 | positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002582) positive regulation of antigen processing and presentation of peptide antigen(GO:0002585) positive regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002588) detection of peptidoglycan(GO:0032499) positive regulation of chemokine-mediated signaling pathway(GO:0070101) |
0.1 | 0.2 | GO:0001544 | initiation of primordial ovarian follicle growth(GO:0001544) |
0.1 | 0.6 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.1 | 0.2 | GO:1901656 | glycoside transport(GO:1901656) |
0.1 | 0.4 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
0.1 | 1.2 | GO:0045023 | G0 to G1 transition(GO:0045023) |
0.1 | 0.5 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.1 | 0.5 | GO:0014028 | notochord formation(GO:0014028) |
0.1 | 0.3 | GO:0034653 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
0.1 | 0.2 | GO:1902161 | positive regulation of cyclic nucleotide-gated ion channel activity(GO:1902161) |
0.1 | 0.3 | GO:0090107 | regulation of high-density lipoprotein particle assembly(GO:0090107) |
0.1 | 0.5 | GO:0071105 | response to interleukin-11(GO:0071105) |
0.1 | 0.2 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
0.1 | 1.0 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.1 | 0.1 | GO:0060994 | regulation of transcription from RNA polymerase II promoter involved in kidney development(GO:0060994) |
0.1 | 0.2 | GO:0071418 | cellular response to amine stimulus(GO:0071418) |
0.1 | 0.4 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
0.1 | 0.4 | GO:0015670 | carbon dioxide transport(GO:0015670) |
0.1 | 0.3 | GO:0019542 | acetate biosynthetic process(GO:0019413) acetyl-CoA biosynthetic process from acetate(GO:0019427) propionate metabolic process(GO:0019541) propionate biosynthetic process(GO:0019542) |
0.1 | 0.2 | GO:0002296 | T-helper 1 cell lineage commitment(GO:0002296) |
0.1 | 0.2 | GO:0072061 | inner medullary collecting duct development(GO:0072061) |
0.1 | 0.1 | GO:0070093 | negative regulation of glucagon secretion(GO:0070093) |
0.1 | 0.5 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.1 | 0.1 | GO:0009826 | unidimensional cell growth(GO:0009826) |
0.1 | 0.2 | GO:2000302 | positive regulation of synaptic vesicle exocytosis(GO:2000302) |
0.1 | 0.7 | GO:1901538 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
0.1 | 0.2 | GO:1903070 | negative regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903070) |
0.1 | 0.5 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
0.1 | 0.2 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.1 | 0.3 | GO:0035625 | negative regulation of epinephrine secretion(GO:0032811) epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) |
0.1 | 0.3 | GO:1901624 | negative regulation of lymphocyte chemotaxis(GO:1901624) |
0.1 | 0.4 | GO:0070383 | DNA cytosine deamination(GO:0070383) |
0.1 | 0.1 | GO:1900195 | positive regulation of oocyte maturation(GO:1900195) |
0.1 | 0.6 | GO:1904715 | negative regulation of chaperone-mediated autophagy(GO:1904715) |
0.1 | 0.3 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.1 | 0.9 | GO:0042048 | olfactory behavior(GO:0042048) |
0.1 | 0.2 | GO:1904640 | response to methionine(GO:1904640) |
0.1 | 0.3 | GO:0033603 | positive regulation of dopamine secretion(GO:0033603) |
0.1 | 0.1 | GO:0060681 | branch elongation involved in ureteric bud branching(GO:0060681) |
0.1 | 0.8 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.1 | 0.4 | GO:0070777 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.1 | 0.2 | GO:0036071 | N-glycan fucosylation(GO:0036071) |
0.1 | 0.1 | GO:0002025 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
0.1 | 0.2 | GO:0045994 | positive regulation of translational initiation by iron(GO:0045994) |
0.1 | 0.2 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
0.1 | 0.4 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) |
0.1 | 0.1 | GO:0006286 | base-excision repair, base-free sugar-phosphate removal(GO:0006286) |
0.1 | 0.6 | GO:0010593 | negative regulation of lamellipodium assembly(GO:0010593) |
0.1 | 0.2 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.1 | 0.6 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
0.1 | 0.1 | GO:0010446 | response to alkaline pH(GO:0010446) |
0.1 | 0.8 | GO:0021702 | cerebellar Purkinje cell layer formation(GO:0021694) cerebellar Purkinje cell differentiation(GO:0021702) |
0.1 | 0.2 | GO:0060313 | negative regulation of neutrophil degranulation(GO:0043314) negative regulation of blood vessel remodeling(GO:0060313) |
0.1 | 0.3 | GO:0001575 | globoside metabolic process(GO:0001575) |
0.1 | 0.2 | GO:0060578 | subthalamic nucleus development(GO:0021763) prolactin secreting cell differentiation(GO:0060127) superior vena cava morphogenesis(GO:0060578) |
0.1 | 0.3 | GO:0048245 | eosinophil chemotaxis(GO:0048245) |
0.1 | 0.3 | GO:0021523 | somatic motor neuron differentiation(GO:0021523) |
0.1 | 0.1 | GO:0008078 | mesodermal cell migration(GO:0008078) |
0.1 | 0.7 | GO:0039530 | MDA-5 signaling pathway(GO:0039530) |
0.1 | 0.6 | GO:0048102 | autophagic cell death(GO:0048102) |
0.1 | 0.3 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.1 | 0.2 | GO:0002316 | follicular B cell differentiation(GO:0002316) |
0.1 | 0.3 | GO:0021943 | formation of radial glial scaffolds(GO:0021943) |
0.1 | 1.0 | GO:0060742 | epithelial cell differentiation involved in prostate gland development(GO:0060742) |
0.1 | 0.2 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) |
0.1 | 0.2 | GO:0090370 | negative regulation of cholesterol efflux(GO:0090370) |
0.1 | 0.3 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.1 | 0.2 | GO:0044278 | cell wall disruption in other organism(GO:0044278) |
0.1 | 0.2 | GO:0006434 | seryl-tRNA aminoacylation(GO:0006434) |
0.1 | 0.2 | GO:0051596 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
0.1 | 0.8 | GO:1901407 | regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) |
0.1 | 0.2 | GO:0046967 | cytosol to ER transport(GO:0046967) |
0.1 | 0.2 | GO:1902080 | positive regulation of relaxation of cardiac muscle(GO:1901899) regulation of calcium ion import into sarcoplasmic reticulum(GO:1902080) negative regulation of calcium ion import into sarcoplasmic reticulum(GO:1902081) |
0.1 | 0.3 | GO:0070458 | cellular detoxification of nitrogen compound(GO:0070458) |
0.1 | 0.2 | GO:0001994 | norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001994) |
0.1 | 0.2 | GO:1905154 | negative regulation of membrane invagination(GO:1905154) |
0.1 | 0.2 | GO:1904346 | positive regulation of growth rate(GO:0040010) negative regulation of circadian sleep/wake cycle, REM sleep(GO:0042322) regulation of gastric mucosal blood circulation(GO:1904344) positive regulation of gastric mucosal blood circulation(GO:1904346) gastric mucosal blood circulation(GO:1990768) |
0.1 | 0.4 | GO:1901098 | positive regulation of autophagosome maturation(GO:1901098) |
0.1 | 0.2 | GO:1900085 | negative regulation of peptidyl-tyrosine autophosphorylation(GO:1900085) negative regulation of inward rectifier potassium channel activity(GO:1903609) |
0.1 | 0.2 | GO:0052314 | terpene metabolic process(GO:0042214) phytoalexin metabolic process(GO:0052314) |
0.1 | 0.6 | GO:0006777 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) |
0.0 | 1.1 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
0.0 | 0.2 | GO:0070901 | mitochondrial tRNA methylation(GO:0070901) |
0.0 | 0.2 | GO:0000960 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
0.0 | 0.2 | GO:0036079 | GDP-fucose transport(GO:0015783) purine nucleotide-sugar transport(GO:0036079) |
0.0 | 0.4 | GO:0021521 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
0.0 | 0.1 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.0 | 0.1 | GO:0048627 | myoblast development(GO:0048627) |
0.0 | 0.4 | GO:0099566 | regulation of postsynaptic cytosolic calcium ion concentration(GO:0099566) |
0.0 | 0.2 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
0.0 | 0.2 | GO:0046462 | monoacylglycerol metabolic process(GO:0046462) monoacylglycerol catabolic process(GO:0052651) |
0.0 | 0.5 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.0 | 0.1 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
0.0 | 0.3 | GO:0051342 | regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051342) negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
0.0 | 0.2 | GO:0045741 | positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
0.0 | 0.1 | GO:0035290 | trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) |
0.0 | 0.5 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
0.0 | 0.1 | GO:0046947 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
0.0 | 0.2 | GO:1901805 | beta-glucoside metabolic process(GO:1901804) beta-glucoside catabolic process(GO:1901805) positive regulation of neuronal action potential(GO:1904457) |
0.0 | 0.3 | GO:1904381 | Golgi apparatus mannose trimming(GO:1904381) |
0.0 | 0.2 | GO:1900425 | negative regulation of defense response to bacterium(GO:1900425) |
0.0 | 0.3 | GO:0001705 | ectoderm formation(GO:0001705) ectodermal cell fate commitment(GO:0001712) |
0.0 | 0.2 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.0 | 0.2 | GO:0019046 | release from viral latency(GO:0019046) |
0.0 | 0.1 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
0.0 | 0.1 | GO:1902024 | histidine transport(GO:0015817) L-histidine transmembrane transport(GO:0089709) L-histidine transport(GO:1902024) |
0.0 | 0.3 | GO:2000501 | regulation of natural killer cell chemotaxis(GO:2000501) positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.0 | 0.1 | GO:1904430 | negative regulation of t-circle formation(GO:1904430) |
0.0 | 0.1 | GO:0051410 | detoxification of nitrogen compound(GO:0051410) |
0.0 | 0.2 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
0.0 | 0.6 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
0.0 | 0.7 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
0.0 | 0.1 | GO:0002644 | negative regulation of tolerance induction(GO:0002644) |
0.0 | 0.1 | GO:1902871 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) cerebral cortex GABAergic interneuron fate commitment(GO:0021893) positive regulation of neural retina development(GO:0061075) positive regulation of retina development in camera-type eye(GO:1902868) positive regulation of amacrine cell differentiation(GO:1902871) |
0.0 | 0.1 | GO:0006480 | N-terminal protein amino acid methylation(GO:0006480) N-terminal peptidyl-alanine methylation(GO:0018011) N-terminal peptidyl-alanine trimethylation(GO:0018012) N-terminal peptidyl-glycine methylation(GO:0018013) N-terminal peptidyl-proline dimethylation(GO:0018016) peptidyl-alanine modification(GO:0018194) N-terminal peptidyl-proline methylation(GO:0035568) N-terminal peptidyl-serine methylation(GO:0035570) N-terminal peptidyl-serine dimethylation(GO:0035572) N-terminal peptidyl-serine trimethylation(GO:0035573) |
0.0 | 0.3 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.0 | 0.1 | GO:0048250 | mitochondrial iron ion transport(GO:0048250) |
0.0 | 0.1 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
0.0 | 0.3 | GO:0032782 | bile acid secretion(GO:0032782) |
0.0 | 0.2 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.0 | 1.4 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.0 | 0.1 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
0.0 | 0.1 | GO:0007227 | signal transduction downstream of smoothened(GO:0007227) positive regulation of hh target transcription factor activity(GO:0007228) |
0.0 | 1.6 | GO:1903861 | positive regulation of dendrite extension(GO:1903861) |
0.0 | 0.4 | GO:1903943 | regulation of hepatocyte apoptotic process(GO:1903943) negative regulation of hepatocyte apoptotic process(GO:1903944) |
0.0 | 0.4 | GO:0043587 | tongue morphogenesis(GO:0043587) |
0.0 | 0.1 | GO:0038091 | VEGF-activated platelet-derived growth factor receptor signaling pathway(GO:0038086) positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway(GO:0038091) |
0.0 | 0.2 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
0.0 | 0.5 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.0 | 1.0 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.0 | 0.7 | GO:0098780 | response to mitochondrial depolarisation(GO:0098780) |
0.0 | 0.5 | GO:0033227 | dsRNA transport(GO:0033227) |
0.0 | 1.0 | GO:0034162 | toll-like receptor 9 signaling pathway(GO:0034162) |
0.0 | 0.3 | GO:0071907 | determination of digestive tract left/right asymmetry(GO:0071907) |
0.0 | 0.1 | GO:0048213 | Golgi vesicle prefusion complex stabilization(GO:0048213) |
0.0 | 0.7 | GO:0090178 | regulation of establishment of planar polarity involved in neural tube closure(GO:0090178) planar cell polarity pathway involved in neural tube closure(GO:0090179) |
0.0 | 0.2 | GO:0019470 | 4-hydroxyproline catabolic process(GO:0019470) |
0.0 | 0.2 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
0.0 | 0.7 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.0 | 0.1 | GO:0019285 | glycine betaine biosynthetic process from choline(GO:0019285) glycine betaine metabolic process(GO:0031455) glycine betaine biosynthetic process(GO:0031456) |
0.0 | 1.2 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.0 | 0.1 | GO:0036378 | alkaloid catabolic process(GO:0009822) calcitriol biosynthetic process from calciol(GO:0036378) |
0.0 | 0.2 | GO:0071918 | urea transmembrane transport(GO:0071918) |
0.0 | 0.1 | GO:0043307 | eosinophil activation involved in immune response(GO:0002278) eosinophil mediated immunity(GO:0002447) eosinophil activation(GO:0043307) eosinophil degranulation(GO:0043308) |
0.0 | 0.4 | GO:0015747 | urate transport(GO:0015747) |
0.0 | 0.2 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.0 | 0.1 | GO:0002884 | negative regulation of type IV hypersensitivity(GO:0001808) negative regulation of hypersensitivity(GO:0002884) |
0.0 | 0.4 | GO:0002693 | positive regulation of cellular extravasation(GO:0002693) |
0.0 | 0.4 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.0 | 0.1 | GO:1902512 | positive regulation of apoptotic DNA fragmentation(GO:1902512) |
0.0 | 0.1 | GO:0002326 | B cell lineage commitment(GO:0002326) |
0.0 | 0.2 | GO:0015688 | iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
0.0 | 0.3 | GO:0038003 | opioid receptor signaling pathway(GO:0038003) |
0.0 | 0.3 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
0.0 | 0.4 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
0.0 | 0.1 | GO:0050760 | negative regulation of thymidylate synthase biosynthetic process(GO:0050760) |
0.0 | 0.4 | GO:0043931 | ossification involved in bone maturation(GO:0043931) |
0.0 | 0.3 | GO:0060033 | anatomical structure regression(GO:0060033) |
0.0 | 0.1 | GO:0035359 | negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
0.0 | 0.1 | GO:1902528 | regulation of protein linear polyubiquitination(GO:1902528) positive regulation of protein linear polyubiquitination(GO:1902530) |
0.0 | 0.1 | GO:1903722 | regulation of centriole elongation(GO:1903722) |
0.0 | 0.5 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.0 | 0.2 | GO:0072313 | metanephric glomerular epithelium development(GO:0072244) metanephric glomerular visceral epithelial cell differentiation(GO:0072248) metanephric glomerular visceral epithelial cell development(GO:0072249) metanephric glomerular epithelial cell differentiation(GO:0072312) metanephric glomerular epithelial cell development(GO:0072313) |
0.0 | 0.2 | GO:1903899 | positive regulation of PERK-mediated unfolded protein response(GO:1903899) |
0.0 | 0.2 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.0 | 0.2 | GO:0090063 | positive regulation of microtubule nucleation(GO:0090063) |
0.0 | 0.1 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
0.0 | 1.7 | GO:0033173 | calcineurin-NFAT signaling cascade(GO:0033173) |
0.0 | 0.8 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.0 | 0.0 | GO:1990535 | neuron projection maintenance(GO:1990535) |
0.0 | 0.1 | GO:0032776 | DNA methylation on cytosine(GO:0032776) |
0.0 | 0.5 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.0 | 0.1 | GO:1902766 | skeletal muscle satellite cell migration(GO:1902766) |
0.0 | 0.1 | GO:0019858 | cytosine metabolic process(GO:0019858) |
0.0 | 0.2 | GO:0015705 | iodide transport(GO:0015705) |
0.0 | 0.1 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.0 | 0.1 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.0 | 0.4 | GO:0014041 | regulation of neuron maturation(GO:0014041) |
0.0 | 0.5 | GO:0090344 | negative regulation of cell aging(GO:0090344) |
0.0 | 0.1 | GO:0009439 | cyanate metabolic process(GO:0009439) cyanate catabolic process(GO:0009440) |
0.0 | 0.2 | GO:0044806 | G-quadruplex DNA unwinding(GO:0044806) cellular response to camptothecin(GO:0072757) |
0.0 | 0.1 | GO:0032571 | response to vitamin K(GO:0032571) |
0.0 | 0.2 | GO:0002786 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antimicrobial humoral response(GO:0002760) regulation of antimicrobial peptide production(GO:0002784) regulation of antibacterial peptide production(GO:0002786) positive regulation of antibacterial peptide production(GO:0002803) |
0.0 | 0.1 | GO:0000415 | negative regulation of histone H3-K36 methylation(GO:0000415) |
0.0 | 0.1 | GO:1904158 | axonemal central apparatus assembly(GO:1904158) |
0.0 | 0.1 | GO:0042323 | negative regulation of circadian sleep/wake cycle, non-REM sleep(GO:0042323) negative regulation of mucus secretion(GO:0070256) |
0.0 | 0.1 | GO:0010902 | positive regulation of very-low-density lipoprotein particle remodeling(GO:0010902) |
0.0 | 1.1 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.0 | 0.3 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
0.0 | 0.1 | GO:0042695 | thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
0.0 | 0.1 | GO:0071802 | negative regulation of podosome assembly(GO:0071802) |
0.0 | 0.1 | GO:1903400 | L-arginine transmembrane transport(GO:1903400) |
0.0 | 1.2 | GO:0032456 | endocytic recycling(GO:0032456) |
0.0 | 0.2 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.0 | 0.1 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
0.0 | 0.3 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
0.0 | 0.1 | GO:0099640 | axo-dendritic protein transport(GO:0099640) |
0.0 | 0.9 | GO:0035729 | cellular response to hepatocyte growth factor stimulus(GO:0035729) |
0.0 | 0.1 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.0 | 0.2 | GO:0040032 | post-embryonic body morphogenesis(GO:0040032) |
0.0 | 0.3 | GO:0097398 | response to interleukin-17(GO:0097396) cellular response to interleukin-17(GO:0097398) |
0.0 | 0.7 | GO:0046475 | glycerophospholipid catabolic process(GO:0046475) |
0.0 | 0.0 | GO:0060018 | astrocyte fate commitment(GO:0060018) |
0.0 | 0.4 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.0 | 0.1 | GO:0046900 | tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
0.0 | 0.1 | GO:0048105 | establishment of body hair or bristle planar orientation(GO:0048104) establishment of body hair planar orientation(GO:0048105) |
0.0 | 0.3 | GO:0051024 | positive regulation of immunoglobulin secretion(GO:0051024) |
0.0 | 0.3 | GO:0032342 | aldosterone metabolic process(GO:0032341) aldosterone biosynthetic process(GO:0032342) |
0.0 | 0.2 | GO:0060125 | habituation(GO:0046959) negative regulation of growth hormone secretion(GO:0060125) |
0.0 | 0.1 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
0.0 | 0.2 | GO:0071257 | cellular response to electrical stimulus(GO:0071257) |
0.0 | 0.2 | GO:0097167 | circadian regulation of translation(GO:0097167) |
0.0 | 0.1 | GO:0006500 | N-terminal protein palmitoylation(GO:0006500) |
0.0 | 0.1 | GO:0032581 | ER-dependent peroxisome organization(GO:0032581) |
0.0 | 0.1 | GO:0060770 | regulation of epithelial cell proliferation involved in prostate gland development(GO:0060768) negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.0 | 0.1 | GO:0071922 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.0 | 0.1 | GO:0060501 | positive regulation of epithelial cell proliferation involved in lung morphogenesis(GO:0060501) |
0.0 | 0.2 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.0 | 0.4 | GO:0006491 | N-glycan processing(GO:0006491) |
0.0 | 0.3 | GO:0007398 | ectoderm development(GO:0007398) |
0.0 | 0.1 | GO:0033159 | negative regulation of protein import into nucleus, translocation(GO:0033159) |
0.0 | 0.5 | GO:0006744 | ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
0.0 | 0.2 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
0.0 | 0.1 | GO:0008582 | regulation of synaptic growth at neuromuscular junction(GO:0008582) |
0.0 | 0.2 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.0 | 0.4 | GO:1900273 | positive regulation of long-term synaptic potentiation(GO:1900273) |
0.0 | 0.1 | GO:0060368 | regulation of Fc receptor mediated stimulatory signaling pathway(GO:0060368) |
0.0 | 0.3 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.0 | 0.2 | GO:0035754 | B cell chemotaxis(GO:0035754) |
0.0 | 0.1 | GO:0050747 | positive regulation of lipoprotein metabolic process(GO:0050747) |
0.0 | 0.3 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
0.0 | 0.5 | GO:0006972 | hyperosmotic response(GO:0006972) |
0.0 | 1.0 | GO:1904837 | beta-catenin-TCF complex assembly(GO:1904837) |
0.0 | 0.6 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.0 | 0.1 | GO:0045656 | negative regulation of monocyte differentiation(GO:0045656) |
0.0 | 0.2 | GO:0032049 | cardiolipin biosynthetic process(GO:0032049) |
0.0 | 0.1 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.0 | 0.1 | GO:2000124 | regulation of endocannabinoid signaling pathway(GO:2000124) |
0.0 | 0.1 | GO:0047484 | regulation of response to osmotic stress(GO:0047484) |
0.0 | 0.2 | GO:0010454 | negative regulation of cell fate commitment(GO:0010454) |
0.0 | 0.2 | GO:0006548 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
0.0 | 0.1 | GO:0002933 | lipid hydroxylation(GO:0002933) |
0.0 | 0.2 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
0.0 | 0.3 | GO:0072189 | ureter development(GO:0072189) |
0.0 | 0.1 | GO:0072720 | histone H4-K12 acetylation(GO:0043983) response to dithiothreitol(GO:0072720) |
0.0 | 0.2 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.0 | 0.1 | GO:0035054 | septum secundum development(GO:0003285) embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
0.0 | 0.1 | GO:0009183 | purine deoxyribonucleoside diphosphate biosynthetic process(GO:0009183) |
0.0 | 0.0 | GO:0055064 | chloride ion homeostasis(GO:0055064) |
0.0 | 0.1 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.0 | 0.1 | GO:1904220 | regulation of serine C-palmitoyltransferase activity(GO:1904220) |
0.0 | 0.1 | GO:1902177 | positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902177) |
0.0 | 0.2 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
0.0 | 0.5 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.0 | 0.1 | GO:0030037 | actin filament reorganization involved in cell cycle(GO:0030037) |
0.0 | 0.5 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.0 | 0.1 | GO:0072592 | oxygen metabolic process(GO:0072592) |
0.0 | 0.1 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.0 | 0.3 | GO:0047497 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
0.0 | 0.1 | GO:0007198 | adenylate cyclase-inhibiting serotonin receptor signaling pathway(GO:0007198) |
0.0 | 0.1 | GO:0019074 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
0.0 | 0.1 | GO:0032237 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
0.0 | 0.2 | GO:0006657 | CDP-choline pathway(GO:0006657) |
0.0 | 0.2 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.0 | 0.3 | GO:0003298 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.0 | 0.2 | GO:0032239 | regulation of nucleobase-containing compound transport(GO:0032239) regulation of RNA export from nucleus(GO:0046831) |
0.0 | 0.2 | GO:0072307 | metanephric nephron tubule epithelial cell differentiation(GO:0072257) regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072307) |
0.0 | 0.2 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
0.0 | 0.1 | GO:1901552 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
0.0 | 0.2 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.0 | 0.2 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.0 | 0.0 | GO:1990523 | bone regeneration(GO:1990523) |
0.0 | 0.1 | GO:0032487 | regulation of Rap protein signal transduction(GO:0032487) |
0.0 | 0.1 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
0.0 | 0.3 | GO:0042340 | keratan sulfate catabolic process(GO:0042340) |
0.0 | 0.0 | GO:0060157 | urinary bladder development(GO:0060157) |
0.0 | 0.3 | GO:0097264 | self proteolysis(GO:0097264) |
0.0 | 0.3 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.0 | 0.2 | GO:1903818 | positive regulation of voltage-gated potassium channel activity(GO:1903818) |
0.0 | 0.3 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.0 | 0.1 | GO:0006789 | bilirubin conjugation(GO:0006789) |
0.0 | 0.2 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.0 | 0.3 | GO:0050995 | negative regulation of lipid catabolic process(GO:0050995) |
0.0 | 0.4 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.0 | 0.3 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.0 | 0.1 | GO:0045007 | depurination(GO:0045007) |
0.0 | 0.1 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.0 | 0.1 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.0 | 0.1 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.0 | 0.1 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.0 | 0.7 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
0.0 | 0.1 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.0 | 0.4 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.0 | 0.1 | GO:0071374 | cellular response to parathyroid hormone stimulus(GO:0071374) |
0.0 | 0.2 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.0 | 0.1 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.0 | 0.1 | GO:0097577 | intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
0.0 | 0.3 | GO:0006833 | water transport(GO:0006833) |
0.0 | 0.1 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.0 | 0.2 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.0 | 0.1 | GO:1901841 | regulation of high voltage-gated calcium channel activity(GO:1901841) |
0.0 | 0.1 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
0.0 | 0.1 | GO:0050428 | purine ribonucleoside bisphosphate biosynthetic process(GO:0034036) 3'-phosphoadenosine 5'-phosphosulfate biosynthetic process(GO:0050428) |
0.0 | 0.2 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.0 | 0.1 | GO:2000111 | positive regulation of macrophage apoptotic process(GO:2000111) |
0.0 | 0.1 | GO:0010585 | glutamine secretion(GO:0010585) L-glutamine import(GO:0036229) L-glutamine import into cell(GO:1903803) |
0.0 | 0.2 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.0 | 0.1 | GO:0051552 | flavone metabolic process(GO:0051552) |
0.0 | 0.0 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.0 | 1.0 | GO:0032508 | DNA duplex unwinding(GO:0032508) |
0.0 | 0.1 | GO:0021759 | globus pallidus development(GO:0021759) |
0.0 | 0.0 | GO:0001878 | response to yeast(GO:0001878) |
0.0 | 0.1 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
0.0 | 0.1 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.0 | 0.1 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.0 | 0.1 | GO:0032392 | DNA geometric change(GO:0032392) |
0.0 | 0.4 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.0 | 0.0 | GO:0060392 | negative regulation of SMAD protein import into nucleus(GO:0060392) |
0.0 | 0.0 | GO:0031247 | actin rod assembly(GO:0031247) |
0.0 | 0.1 | GO:0010265 | SCF complex assembly(GO:0010265) |
0.0 | 0.2 | GO:0046697 | decidualization(GO:0046697) |
0.0 | 0.2 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.0 | 0.1 | GO:0045586 | regulation of gamma-delta T cell differentiation(GO:0045586) |
0.0 | 0.4 | GO:0001755 | neural crest cell migration(GO:0001755) |
0.0 | 0.1 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.0 | 0.1 | GO:0061577 | calcium ion transmembrane transport via high voltage-gated calcium channel(GO:0061577) |
0.0 | 0.4 | GO:0030517 | negative regulation of axon extension(GO:0030517) |
0.0 | 0.1 | GO:0035900 | response to isolation stress(GO:0035900) |
0.0 | 0.0 | GO:0014827 | intestine smooth muscle contraction(GO:0014827) |
0.0 | 0.2 | GO:0016024 | CDP-diacylglycerol biosynthetic process(GO:0016024) |
0.0 | 0.0 | GO:0015942 | 10-formyltetrahydrofolate biosynthetic process(GO:0009257) formate metabolic process(GO:0015942) |
0.0 | 0.0 | GO:0044691 | tooth eruption(GO:0044691) |
0.0 | 0.2 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.0 | 0.1 | GO:0006436 | tryptophanyl-tRNA aminoacylation(GO:0006436) |
0.0 | 0.4 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
0.0 | 0.0 | GO:0032455 | nerve growth factor processing(GO:0032455) |
0.0 | 0.0 | GO:0038193 | thromboxane A2 signaling pathway(GO:0038193) |
0.0 | 0.0 | GO:0043366 | beta selection(GO:0043366) |
0.0 | 0.1 | GO:0061737 | leukotriene signaling pathway(GO:0061737) |
0.0 | 0.2 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
0.0 | 0.0 | GO:0031017 | exocrine pancreas development(GO:0031017) |
0.0 | 0.0 | GO:0071504 | cellular response to heparin(GO:0071504) |
0.0 | 0.1 | GO:0009213 | pyrimidine nucleoside triphosphate catabolic process(GO:0009149) pyrimidine deoxyribonucleoside triphosphate catabolic process(GO:0009213) |
0.0 | 0.1 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
0.0 | 0.1 | GO:0010666 | positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
0.0 | 0.2 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.0 | 0.4 | GO:0032469 | endoplasmic reticulum calcium ion homeostasis(GO:0032469) |
0.0 | 0.1 | GO:0015886 | heme transport(GO:0015886) |
0.0 | 0.0 | GO:1903348 | positive regulation of bicellular tight junction assembly(GO:1903348) |
0.0 | 0.1 | GO:0001865 | NK T cell differentiation(GO:0001865) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 2.1 | GO:0071065 | alpha9-beta1 integrin-vascular cell adhesion molecule-1 complex(GO:0071065) |
0.3 | 1.4 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.2 | 0.6 | GO:0044753 | amphisome(GO:0044753) |
0.2 | 0.6 | GO:0019008 | molybdopterin synthase complex(GO:0019008) |
0.1 | 0.6 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.1 | 0.4 | GO:0097059 | CNTFR-CLCF1 complex(GO:0097059) |
0.1 | 0.4 | GO:1990032 | parallel fiber(GO:1990032) |
0.1 | 0.8 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.1 | 0.6 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
0.1 | 0.4 | GO:0097444 | spine apparatus(GO:0097444) |
0.1 | 0.4 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.1 | 0.7 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
0.1 | 0.9 | GO:0098560 | cytoplasmic side of late endosome membrane(GO:0098560) |
0.1 | 0.3 | GO:0072563 | endothelial microparticle(GO:0072563) |
0.1 | 0.5 | GO:0001405 | presequence translocase-associated import motor(GO:0001405) |
0.1 | 0.8 | GO:0005579 | membrane attack complex(GO:0005579) |
0.1 | 0.3 | GO:0031523 | Myb complex(GO:0031523) |
0.1 | 2.4 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.1 | 1.1 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.1 | 1.1 | GO:0030478 | actin cap(GO:0030478) |
0.1 | 0.3 | GO:1990031 | pinceau fiber(GO:1990031) |
0.1 | 0.6 | GO:0005638 | lamin filament(GO:0005638) |
0.1 | 1.1 | GO:0042555 | MCM complex(GO:0042555) |
0.1 | 0.4 | GO:1990682 | CSF1-CSF1R complex(GO:1990682) |
0.1 | 0.5 | GO:0071144 | SMAD2-SMAD3 protein complex(GO:0071144) |
0.1 | 0.4 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.1 | 0.2 | GO:0034751 | aryl hydrocarbon receptor complex(GO:0034751) |
0.1 | 0.1 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.0 | 0.2 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
0.0 | 0.2 | GO:0044308 | axonal spine(GO:0044308) |
0.0 | 0.2 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
0.0 | 1.1 | GO:0031229 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
0.0 | 0.6 | GO:0044327 | dendritic spine head(GO:0044327) |
0.0 | 0.4 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
0.0 | 0.8 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.0 | 0.1 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
0.0 | 0.2 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
0.0 | 0.2 | GO:0044305 | calyx of Held(GO:0044305) |
0.0 | 0.2 | GO:0042567 | insulin-like growth factor ternary complex(GO:0042567) |
0.0 | 0.2 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.0 | 0.5 | GO:0043203 | axon hillock(GO:0043203) |
0.0 | 0.1 | GO:0038038 | G-protein coupled receptor homodimeric complex(GO:0038038) |
0.0 | 0.4 | GO:0000243 | commitment complex(GO:0000243) |
0.0 | 1.2 | GO:0000145 | exocyst(GO:0000145) |
0.0 | 0.4 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.0 | 0.2 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.0 | 0.2 | GO:0030678 | mitochondrial ribonuclease P complex(GO:0030678) |
0.0 | 2.2 | GO:0031201 | SNARE complex(GO:0031201) |
0.0 | 0.1 | GO:1990812 | growth cone filopodium(GO:1990812) |
0.0 | 0.2 | GO:0071458 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) |
0.0 | 0.2 | GO:0045298 | tubulin complex(GO:0045298) |
0.0 | 0.2 | GO:0042825 | TAP complex(GO:0042825) |
0.0 | 0.1 | GO:0060187 | cell pole(GO:0060187) |
0.0 | 0.1 | GO:0034657 | GID complex(GO:0034657) |
0.0 | 0.5 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.0 | 0.2 | GO:1902560 | GMP reductase complex(GO:1902560) |
0.0 | 0.2 | GO:0071817 | MMXD complex(GO:0071817) |
0.0 | 0.1 | GO:0045160 | myosin I complex(GO:0045160) |
0.0 | 0.2 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
0.0 | 0.1 | GO:0036398 | TCR signalosome(GO:0036398) |
0.0 | 0.5 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
0.0 | 0.2 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.0 | 0.1 | GO:0020003 | symbiont-containing vacuole(GO:0020003) symbiont-containing vacuole membrane(GO:0020005) |
0.0 | 0.5 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
0.0 | 0.2 | GO:0005587 | collagen type IV trimer(GO:0005587) |
0.0 | 0.1 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.0 | 0.4 | GO:0031105 | septin complex(GO:0031105) |
0.0 | 0.6 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.0 | 0.1 | GO:0097513 | myosin II filament(GO:0097513) |
0.0 | 0.1 | GO:1903440 | calcitonin family receptor complex(GO:1903439) amylin receptor complex(GO:1903440) |
0.0 | 1.0 | GO:0043034 | costamere(GO:0043034) |
0.0 | 0.2 | GO:0001673 | male germ cell nucleus(GO:0001673) |
0.0 | 0.1 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.0 | 0.4 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.0 | 0.3 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.0 | 0.1 | GO:0097447 | dendritic tree(GO:0097447) |
0.0 | 0.1 | GO:0070876 | SOSS complex(GO:0070876) |
0.0 | 0.1 | GO:1990246 | uniplex complex(GO:1990246) |
0.0 | 0.1 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.0 | 1.1 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.0 | 0.2 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.0 | 0.2 | GO:0042382 | paraspeckles(GO:0042382) |
0.0 | 0.1 | GO:0098575 | lumenal side of lysosomal membrane(GO:0098575) |
0.0 | 0.1 | GO:0097470 | ribbon synapse(GO:0097470) |
0.0 | 0.1 | GO:0008278 | cohesin complex(GO:0008278) |
0.0 | 0.1 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.0 | 0.1 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.0 | 1.2 | GO:0043195 | terminal bouton(GO:0043195) |
0.0 | 0.2 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.0 | 0.4 | GO:0042627 | chylomicron(GO:0042627) |
0.0 | 0.1 | GO:0000221 | vacuolar proton-transporting V-type ATPase, V1 domain(GO:0000221) |
0.0 | 0.1 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.0 | 0.1 | GO:0036021 | endolysosome lumen(GO:0036021) |
0.0 | 0.5 | GO:0031306 | intrinsic component of mitochondrial outer membrane(GO:0031306) |
0.0 | 1.6 | GO:0035578 | azurophil granule lumen(GO:0035578) |
0.0 | 0.1 | GO:1990130 | Iml1 complex(GO:1990130) |
0.0 | 1.0 | GO:0015030 | Cajal body(GO:0015030) |
0.0 | 0.8 | GO:0001772 | immunological synapse(GO:0001772) |
0.0 | 0.1 | GO:0031931 | TORC1 complex(GO:0031931) |
0.0 | 0.9 | GO:0016235 | aggresome(GO:0016235) |
0.0 | 0.1 | GO:0016272 | prefoldin complex(GO:0016272) |
0.0 | 0.1 | GO:0031211 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.0 | 0.1 | GO:1990393 | 3M complex(GO:1990393) |
0.0 | 0.6 | GO:0000795 | synaptonemal complex(GO:0000795) |
0.0 | 1.6 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
0.0 | 1.0 | GO:0005871 | kinesin complex(GO:0005871) |
0.0 | 0.2 | GO:0005869 | dynactin complex(GO:0005869) |
0.0 | 0.2 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
0.0 | 0.1 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.0 | 0.2 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.0 | 0.2 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.0 | 0.1 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.0 | 0.1 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.0 | 0.9 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.0 | 0.1 | GO:0033010 | paranodal junction(GO:0033010) |
0.0 | 0.2 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.0 | 0.2 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 2.5 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
0.3 | 0.8 | GO:0008859 | exoribonuclease II activity(GO:0008859) |
0.2 | 1.8 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.2 | 1.3 | GO:0043183 | vascular endothelial growth factor receptor 1 binding(GO:0043183) |
0.2 | 1.0 | GO:0060175 | brain-derived neurotrophic factor-activated receptor activity(GO:0060175) |
0.2 | 1.4 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
0.2 | 1.0 | GO:0004419 | hydroxymethylglutaryl-CoA lyase activity(GO:0004419) |
0.1 | 0.9 | GO:0004331 | 6-phosphofructo-2-kinase activity(GO:0003873) fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
0.1 | 1.6 | GO:0030274 | LIM domain binding(GO:0030274) |
0.1 | 0.7 | GO:0031728 | CCR3 chemokine receptor binding(GO:0031728) |
0.1 | 0.4 | GO:0004821 | histidine-tRNA ligase activity(GO:0004821) |
0.1 | 0.6 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.1 | 0.7 | GO:0008665 | 2'-phosphotransferase activity(GO:0008665) |
0.1 | 0.1 | GO:0005152 | interleukin-1 receptor antagonist activity(GO:0005152) |
0.1 | 0.3 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
0.1 | 0.4 | GO:0030377 | urokinase plasminogen activator receptor activity(GO:0030377) |
0.1 | 0.4 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.1 | 0.3 | GO:0004347 | glucose-6-phosphate isomerase activity(GO:0004347) |
0.1 | 0.3 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.1 | 0.5 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.1 | 1.2 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.1 | 0.6 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.1 | 0.5 | GO:0031962 | mineralocorticoid receptor binding(GO:0031962) |
0.1 | 0.4 | GO:0008431 | vitamin E binding(GO:0008431) |
0.1 | 0.3 | GO:0034188 | apolipoprotein A-I receptor activity(GO:0034188) phosphatidylserine-translocating ATPase activity(GO:0090556) |
0.1 | 0.3 | GO:0015235 | cobalamin transporter activity(GO:0015235) |
0.1 | 1.9 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.1 | 2.4 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.1 | 0.8 | GO:0001225 | RNA polymerase II transcription coactivator binding(GO:0001225) |
0.1 | 0.3 | GO:0004979 | beta-endorphin receptor activity(GO:0004979) morphine receptor activity(GO:0038047) |
0.1 | 0.3 | GO:0042903 | tubulin deacetylase activity(GO:0042903) |
0.1 | 1.1 | GO:0045159 | myosin II binding(GO:0045159) |
0.1 | 0.5 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.1 | 1.3 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.1 | 0.2 | GO:0034617 | tetrahydrobiopterin binding(GO:0034617) |
0.1 | 0.2 | GO:0005260 | channel-conductance-controlling ATPase activity(GO:0005260) |
0.1 | 0.4 | GO:0047844 | deoxycytidine deaminase activity(GO:0047844) |
0.1 | 0.2 | GO:0016731 | ferredoxin-NADP+ reductase activity(GO:0004324) NADPH-adrenodoxin reductase activity(GO:0015039) oxidoreductase activity, acting on iron-sulfur proteins as donors(GO:0016730) oxidoreductase activity, acting on iron-sulfur proteins as donors, NAD or NADP as acceptor(GO:0016731) |
0.1 | 0.2 | GO:0004852 | uroporphyrinogen-III synthase activity(GO:0004852) |
0.1 | 0.9 | GO:0046870 | cadmium ion binding(GO:0046870) |
0.1 | 0.4 | GO:0016900 | oxidoreductase activity, acting on the CH-OH group of donors, disulfide as acceptor(GO:0016900) vitamin-K-epoxide reductase (warfarin-sensitive) activity(GO:0047057) |
0.1 | 0.4 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.1 | 0.1 | GO:0097604 | temperature-gated cation channel activity(GO:0097604) |
0.1 | 0.2 | GO:0004936 | alpha-adrenergic receptor activity(GO:0004936) alpha1-adrenergic receptor activity(GO:0004937) |
0.1 | 0.3 | GO:0022865 | transmembrane electron transfer carrier(GO:0022865) |
0.1 | 0.3 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
0.1 | 0.2 | GO:0034353 | RNA pyrophosphohydrolase activity(GO:0034353) |
0.1 | 0.7 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.1 | 0.6 | GO:0010853 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.1 | 0.2 | GO:0003858 | 3-hydroxybutyrate dehydrogenase activity(GO:0003858) |
0.1 | 0.2 | GO:0017057 | 6-phosphogluconolactonase activity(GO:0017057) |
0.1 | 0.1 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.1 | 1.0 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
0.1 | 0.8 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.1 | 0.1 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
0.1 | 0.2 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.1 | 0.4 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.1 | 0.2 | GO:0003826 | alpha-ketoacid dehydrogenase activity(GO:0003826) 3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity(GO:0003863) |
0.1 | 0.4 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
0.1 | 0.2 | GO:0046921 | glycoprotein 6-alpha-L-fucosyltransferase activity(GO:0008424) alpha-(1->6)-fucosyltransferase activity(GO:0046921) |
0.1 | 1.7 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.1 | 0.3 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.1 | 0.4 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.1 | 0.3 | GO:0004906 | interferon-gamma receptor activity(GO:0004906) |
0.1 | 0.3 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.1 | 0.2 | GO:0004103 | choline kinase activity(GO:0004103) |
0.1 | 0.3 | GO:0070644 | vitamin D response element binding(GO:0070644) |
0.1 | 0.3 | GO:0019828 | aspartic-type endopeptidase inhibitor activity(GO:0019828) |
0.1 | 0.6 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
0.1 | 0.9 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.1 | 0.6 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.1 | 0.3 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.1 | 1.2 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.1 | 0.4 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.1 | 0.2 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.1 | 0.2 | GO:0099609 | microtubule lateral binding(GO:0099609) |
0.1 | 0.2 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.1 | 0.2 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
0.1 | 0.2 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.1 | 0.2 | GO:0031768 | ghrelin receptor binding(GO:0031768) |
0.1 | 0.2 | GO:0016402 | pristanoyl-CoA oxidase activity(GO:0016402) |
0.1 | 0.2 | GO:0070320 | inward rectifier potassium channel inhibitor activity(GO:0070320) |
0.1 | 0.3 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.0 | 2.0 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
0.0 | 0.2 | GO:0016784 | 3-mercaptopyruvate sulfurtransferase activity(GO:0016784) |
0.0 | 0.4 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.0 | 0.2 | GO:0005457 | GDP-fucose transmembrane transporter activity(GO:0005457) purine nucleotide-sugar transmembrane transporter activity(GO:0036080) |
0.0 | 0.4 | GO:0005534 | galactose binding(GO:0005534) |
0.0 | 0.3 | GO:0052654 | branched-chain-amino-acid transaminase activity(GO:0004084) L-leucine transaminase activity(GO:0052654) L-valine transaminase activity(GO:0052655) L-isoleucine transaminase activity(GO:0052656) |
0.0 | 0.4 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.0 | 0.4 | GO:0099583 | neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration(GO:0099583) |
0.0 | 0.1 | GO:0004507 | steroid 11-beta-monooxygenase activity(GO:0004507) corticosterone 18-monooxygenase activity(GO:0047783) |
0.0 | 0.2 | GO:0004657 | proline dehydrogenase activity(GO:0004657) |
0.0 | 0.3 | GO:0051021 | GDP-dissociation inhibitor binding(GO:0051021) Rho GDP-dissociation inhibitor binding(GO:0051022) |
0.0 | 0.1 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.0 | 0.4 | GO:1990446 | U1 snRNP binding(GO:1990446) |
0.0 | 0.1 | GO:0033823 | procollagen-lysine 5-dioxygenase activity(GO:0008475) procollagen glucosyltransferase activity(GO:0033823) |
0.0 | 0.3 | GO:0015065 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.0 | 0.2 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.0 | 0.4 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.0 | 0.3 | GO:0017077 | oxidative phosphorylation uncoupler activity(GO:0017077) |
0.0 | 0.8 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.0 | 0.3 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.0 | 0.6 | GO:0005372 | water transmembrane transporter activity(GO:0005372) water channel activity(GO:0015250) |
0.0 | 0.1 | GO:0071885 | N-terminal protein N-methyltransferase activity(GO:0071885) |
0.0 | 0.1 | GO:0070984 | SET domain binding(GO:0070984) |
0.0 | 0.1 | GO:0015439 | heme-transporting ATPase activity(GO:0015439) |
0.0 | 2.1 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.0 | 0.1 | GO:0047696 | beta-adrenergic receptor kinase activity(GO:0047696) |
0.0 | 1.1 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.0 | 0.2 | GO:0031705 | bombesin receptor binding(GO:0031705) |
0.0 | 0.1 | GO:0051380 | beta-adrenergic receptor activity(GO:0004939) norepinephrine binding(GO:0051380) |
0.0 | 0.1 | GO:0017095 | heparan sulfate 6-O-sulfotransferase activity(GO:0017095) |
0.0 | 0.2 | GO:0004530 | deoxyribonuclease I activity(GO:0004530) |
0.0 | 0.2 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.0 | 0.8 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.0 | 0.1 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.0 | 1.0 | GO:0004467 | long-chain fatty acid-CoA ligase activity(GO:0004467) |
0.0 | 0.1 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.0 | 0.3 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.0 | 0.1 | GO:0030343 | vitamin D3 25-hydroxylase activity(GO:0030343) vitamin D 25-hydroxylase activity(GO:0070643) |
0.0 | 0.2 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
0.0 | 0.3 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.0 | 0.4 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
0.0 | 0.2 | GO:0004348 | glucosylceramidase activity(GO:0004348) |
0.0 | 0.2 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.0 | 0.6 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.0 | 0.1 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.0 | 0.3 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
0.0 | 0.1 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.0 | 0.3 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.0 | 1.0 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.0 | 1.5 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.0 | 1.0 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.0 | 0.3 | GO:0008430 | selenium binding(GO:0008430) |
0.0 | 0.1 | GO:0033149 | FFAT motif binding(GO:0033149) |
0.0 | 0.6 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.0 | 0.2 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.0 | 0.6 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.0 | 0.5 | GO:0019841 | retinol binding(GO:0019841) |
0.0 | 0.2 | GO:0047237 | glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047237) |
0.0 | 0.3 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.0 | 0.4 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.0 | 0.1 | GO:0061628 | H3K27me3 modified histone binding(GO:0061628) |
0.0 | 0.1 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.0 | 0.1 | GO:0002060 | purine nucleobase binding(GO:0002060) |
0.0 | 0.1 | GO:0005017 | platelet-derived growth factor-activated receptor activity(GO:0005017) |
0.0 | 0.2 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
0.0 | 0.2 | GO:0009378 | four-way junction helicase activity(GO:0009378) |
0.0 | 0.5 | GO:0015217 | ATP transmembrane transporter activity(GO:0005347) ADP transmembrane transporter activity(GO:0015217) |
0.0 | 0.8 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.0 | 0.4 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.0 | 1.0 | GO:0008187 | poly-pyrimidine tract binding(GO:0008187) |
0.0 | 0.1 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.0 | 0.1 | GO:0004608 | phosphatidyl-N-methylethanolamine N-methyltransferase activity(GO:0000773) phosphatidylethanolamine N-methyltransferase activity(GO:0004608) phosphatidyl-N-dimethylethanolamine N-methyltransferase activity(GO:0080101) |
0.0 | 0.2 | GO:0003920 | GMP reductase activity(GO:0003920) oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor(GO:0016657) |
0.0 | 0.2 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.0 | 1.1 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.0 | 0.9 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.0 | 0.9 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.0 | 0.2 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.0 | 0.1 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.0 | 1.0 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.0 | 0.8 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.0 | 0.1 | GO:0008426 | protein kinase C inhibitor activity(GO:0008426) |
0.0 | 0.2 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
0.0 | 0.1 | GO:0033265 | choline binding(GO:0033265) |
0.0 | 0.2 | GO:0015186 | L-glutamine transmembrane transporter activity(GO:0015186) |
0.0 | 0.1 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.0 | 0.1 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.0 | 0.4 | GO:0042834 | peptidoglycan binding(GO:0042834) |
0.0 | 0.9 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.0 | 0.7 | GO:0019707 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
0.0 | 0.2 | GO:0005497 | androgen binding(GO:0005497) |
0.0 | 1.4 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) |
0.0 | 0.2 | GO:0016015 | morphogen activity(GO:0016015) |
0.0 | 0.3 | GO:0015643 | toxic substance binding(GO:0015643) |
0.0 | 0.1 | GO:0004105 | choline-phosphate cytidylyltransferase activity(GO:0004105) |
0.0 | 0.2 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.0 | 0.4 | GO:0016638 | oxidoreductase activity, acting on the CH-NH2 group of donors(GO:0016638) |
0.0 | 0.1 | GO:0043532 | angiostatin binding(GO:0043532) |
0.0 | 0.2 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.0 | 0.1 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.0 | 0.1 | GO:0017040 | ceramidase activity(GO:0017040) |
0.0 | 0.2 | GO:0070740 | tubulin-glutamic acid ligase activity(GO:0070740) |
0.0 | 0.2 | GO:0035174 | histone serine kinase activity(GO:0035174) |
0.0 | 0.1 | GO:0042015 | interleukin-10 receptor activity(GO:0004920) interleukin-20 binding(GO:0042015) |
0.0 | 0.2 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.0 | 0.1 | GO:0016454 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
0.0 | 0.3 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.0 | 0.2 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.0 | 0.1 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.0 | 0.2 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.0 | 0.1 | GO:0090541 | MIT domain binding(GO:0090541) |
0.0 | 0.1 | GO:0098808 | mRNA cap binding(GO:0098808) |
0.0 | 0.4 | GO:0008009 | chemokine activity(GO:0008009) |
0.0 | 0.6 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
0.0 | 0.3 | GO:0008296 | 3'-5'-exodeoxyribonuclease activity(GO:0008296) |
0.0 | 0.3 | GO:0050693 | LBD domain binding(GO:0050693) |
0.0 | 0.3 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) |
0.0 | 0.6 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.0 | 0.2 | GO:0004308 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) |
0.0 | 0.2 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.0 | 0.1 | GO:0031996 | thioesterase binding(GO:0031996) |
0.0 | 0.1 | GO:0050659 | N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity(GO:0050659) |
0.0 | 0.1 | GO:0051916 | granulocyte colony-stimulating factor binding(GO:0051916) |
0.0 | 0.3 | GO:0044213 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) intronic transcription regulatory region DNA binding(GO:0044213) |
0.0 | 0.1 | GO:0016416 | carnitine O-palmitoyltransferase activity(GO:0004095) O-palmitoyltransferase activity(GO:0016416) |
0.0 | 0.3 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.0 | 0.3 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.0 | 0.1 | GO:0001632 | leukotriene B4 receptor activity(GO:0001632) |
0.0 | 0.4 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.0 | 0.1 | GO:0032406 | MutLbeta complex binding(GO:0032406) MutSbeta complex binding(GO:0032408) |
0.0 | 0.1 | GO:0005046 | KDEL sequence binding(GO:0005046) |
0.0 | 0.4 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.0 | 0.1 | GO:0004947 | bradykinin receptor activity(GO:0004947) |
0.0 | 0.6 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.0 | 0.1 | GO:0042799 | histone methyltransferase activity (H4-K20 specific)(GO:0042799) |
0.0 | 0.1 | GO:0004473 | malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) malate dehydrogenase (decarboxylating) (NADP+) activity(GO:0004473) |
0.0 | 0.6 | GO:0030506 | ankyrin binding(GO:0030506) |
0.0 | 0.4 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.0 | 0.1 | GO:0005280 | hydrogen:amino acid symporter activity(GO:0005280) |
0.0 | 0.7 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
0.0 | 0.1 | GO:0008336 | gamma-butyrobetaine dioxygenase activity(GO:0008336) |
0.0 | 0.1 | GO:0030267 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
0.0 | 0.4 | GO:0017166 | vinculin binding(GO:0017166) |
0.0 | 0.1 | GO:0030350 | iron-responsive element binding(GO:0030350) |
0.0 | 0.1 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.0 | 0.1 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.0 | 0.1 | GO:0003835 | beta-galactoside alpha-2,6-sialyltransferase activity(GO:0003835) |
0.0 | 0.1 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.0 | 0.2 | GO:0019534 | toxin transporter activity(GO:0019534) |
0.0 | 0.8 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.0 | 0.2 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) corticotropin-releasing hormone receptor 1 binding(GO:0051430) |
0.0 | 0.1 | GO:0044736 | acid-sensing ion channel activity(GO:0044736) |
0.0 | 0.2 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.0 | 0.3 | GO:0038191 | neuropilin binding(GO:0038191) |
0.0 | 0.4 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.0 | 0.7 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.0 | 0.0 | GO:0032093 | nucleosomal histone binding(GO:0031493) SAM domain binding(GO:0032093) |
0.0 | 0.3 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.0 | 2.7 | GO:0005125 | cytokine activity(GO:0005125) |
0.0 | 0.1 | GO:0030172 | troponin C binding(GO:0030172) |
0.0 | 0.4 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.0 | 0.2 | GO:0043996 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.0 | 0.2 | GO:0005522 | profilin binding(GO:0005522) |
0.0 | 0.1 | GO:0097506 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
0.0 | 0.2 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.0 | 0.8 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.0 | 0.1 | GO:0005292 | high-affinity basic amino acid transmembrane transporter activity(GO:0005287) high-affinity arginine transmembrane transporter activity(GO:0005289) high-affinity lysine transmembrane transporter activity(GO:0005292) |
0.0 | 0.1 | GO:0015307 | drug:proton antiporter activity(GO:0015307) |
0.0 | 0.1 | GO:0004991 | parathyroid hormone receptor activity(GO:0004991) |
0.0 | 0.5 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.0 | 0.3 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
0.0 | 0.1 | GO:0005294 | neutral L-amino acid secondary active transmembrane transporter activity(GO:0005294) |
0.0 | 0.1 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.0 | 0.1 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.0 | 2.2 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.0 | 1.3 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.0 | 0.3 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.0 | 0.1 | GO:0048256 | flap endonuclease activity(GO:0048256) |
0.0 | 0.2 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.0 | 1.7 | GO:0008081 | phosphoric diester hydrolase activity(GO:0008081) |
0.0 | 0.1 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.0 | 0.1 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.0 | 0.1 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
0.0 | 0.3 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.0 | 0.1 | GO:0003996 | acyl-CoA ligase activity(GO:0003996) |
0.0 | 0.0 | GO:0004329 | formate-tetrahydrofolate ligase activity(GO:0004329) |
0.0 | 4.1 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.0 | 0.2 | GO:0044548 | S100 protein binding(GO:0044548) |
0.0 | 0.1 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
0.0 | 0.1 | GO:0004830 | tryptophan-tRNA ligase activity(GO:0004830) |
0.0 | 0.6 | GO:0050699 | WW domain binding(GO:0050699) |
0.0 | 0.0 | GO:0004961 | thromboxane receptor activity(GO:0004960) thromboxane A2 receptor activity(GO:0004961) |
0.0 | 0.1 | GO:0001733 | galactosylceramide sulfotransferase activity(GO:0001733) galactose 3-O-sulfotransferase activity(GO:0050694) |
0.0 | 0.1 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
0.0 | 0.1 | GO:0048156 | tau protein binding(GO:0048156) |
0.0 | 0.1 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.0 | 0.2 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.0 | 0.1 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.0 | 0.2 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.0 | 0.2 | GO:0043295 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.0 | 0.3 | GO:0008171 | O-methyltransferase activity(GO:0008171) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 0.3 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.1 | 5.7 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.1 | 1.4 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.1 | 2.2 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.1 | 2.2 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.0 | 3.0 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.0 | 0.2 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.0 | 0.6 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.0 | 0.1 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.0 | 1.1 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.0 | 1.8 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.0 | 1.7 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.0 | 0.2 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.0 | 1.0 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.0 | 1.1 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.0 | 1.1 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.0 | 1.0 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.0 | 0.8 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.0 | 0.4 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.0 | 0.6 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.0 | 1.3 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.0 | 2.0 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.0 | 0.3 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.0 | 0.3 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.0 | 0.8 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.0 | 0.3 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.0 | 0.9 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.0 | 0.3 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.0 | 0.9 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.0 | 0.1 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.0 | 0.2 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.0 | 0.5 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.0 | 0.6 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.0 | 0.5 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.0 | 0.9 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.0 | 0.3 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.0 | 0.5 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.0 | 0.8 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.0 | 0.3 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.0 | 1.2 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.0 | 0.6 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.0 | 1.4 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.0 | 0.7 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.0 | 0.4 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.0 | 0.2 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.0 | 0.2 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.0 | 0.6 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.0 | 0.3 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.0 | 0.3 | PID ARF 3PATHWAY | Arf1 pathway |
0.0 | 0.2 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.0 | 0.3 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.0 | 0.5 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.0 | 0.2 | PID IL2 1PATHWAY | IL2-mediated signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 2.7 | REACTOME P75NTR RECRUITS SIGNALLING COMPLEXES | Genes involved in p75NTR recruits signalling complexes |
0.1 | 1.9 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.1 | 2.4 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.1 | 2.0 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.1 | 7.7 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.1 | 0.5 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
0.1 | 1.4 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.1 | 1.1 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.1 | 1.0 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.1 | 2.0 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.1 | 0.4 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.0 | 1.9 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.0 | 0.8 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.0 | 0.6 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.0 | 1.3 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
0.0 | 0.4 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.0 | 0.4 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.0 | 0.9 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.0 | 2.4 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.0 | 2.1 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.0 | 0.4 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.0 | 0.9 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
0.0 | 1.5 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.0 | 0.9 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.0 | 0.1 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.0 | 0.1 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.0 | 0.3 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.0 | 0.4 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.0 | 1.4 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.0 | 0.9 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.0 | 0.1 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.0 | 0.4 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.0 | 0.4 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.0 | 0.1 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.0 | 0.4 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.0 | 1.5 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.0 | 1.6 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.0 | 0.3 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.0 | 0.2 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.0 | 0.3 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.0 | 0.3 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.0 | 0.8 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.0 | 0.5 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.0 | 0.7 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.0 | 0.5 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.0 | 0.6 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.0 | 0.2 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
0.0 | 0.1 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.0 | 0.4 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.0 | 0.4 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.0 | 0.8 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.0 | 0.3 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.0 | 0.8 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.0 | 0.7 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.0 | 0.3 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.0 | 0.7 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.0 | 0.4 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.0 | 0.4 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
0.0 | 0.3 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.0 | 0.4 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.0 | 0.2 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.0 | 0.2 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
0.0 | 0.3 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.0 | 0.9 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.0 | 0.3 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.0 | 0.1 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.0 | 1.2 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.0 | 0.5 | REACTOME CELL CELL JUNCTION ORGANIZATION | Genes involved in Cell-cell junction organization |
0.0 | 0.1 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.0 | 0.2 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.0 | 0.0 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.0 | 0.2 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.0 | 0.4 | REACTOME KINESINS | Genes involved in Kinesins |
0.0 | 0.3 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |